AUPP350198A0 - Method for diagnosing or assessing a predisposition to alzheimer's disease - Google Patents

Method for diagnosing or assessing a predisposition to alzheimer's disease

Info

Publication number
AUPP350198A0
AUPP350198A0 AUPP3501A AUPP350198A AUPP350198A0 AU PP350198 A0 AUPP350198 A0 AU PP350198A0 AU PP3501 A AUPP3501 A AU PP3501A AU PP350198 A AUPP350198 A AU PP350198A AU PP350198 A0 AUPP350198 A0 AU PP350198A0
Authority
AU
Australia
Prior art keywords
predisposition
alzheimer
diagnosing
assessing
disease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AUPP3501A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Garvan Institute of Medical Research
Original Assignee
Garvan Institute of Medical Research
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Garvan Institute of Medical Research filed Critical Garvan Institute of Medical Research
Priority to AUPP3501A priority Critical patent/AUPP350198A0/en
Publication of AUPP350198A0 publication Critical patent/AUPP350198A0/en
Priority to AU38032/99A priority patent/AU3803299A/en
Priority to PCT/AU1999/000362 priority patent/WO1999058711A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/172—Haplotypes
AUPP3501A 1998-05-13 1998-05-13 Method for diagnosing or assessing a predisposition to alzheimer's disease Abandoned AUPP350198A0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
AUPP3501A AUPP350198A0 (en) 1998-05-13 1998-05-13 Method for diagnosing or assessing a predisposition to alzheimer's disease
AU38032/99A AU3803299A (en) 1998-05-13 1999-05-13 Method for diagnosing or assessing a predisposition to alzheimer's disease
PCT/AU1999/000362 WO1999058711A1 (en) 1998-05-13 1999-05-13 Method for diagnosing or assessing a predisposition to alzheimer's disease

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPP3501A AUPP350198A0 (en) 1998-05-13 1998-05-13 Method for diagnosing or assessing a predisposition to alzheimer's disease

Publications (1)

Publication Number Publication Date
AUPP350198A0 true AUPP350198A0 (en) 1998-06-04

Family

ID=3807754

Family Applications (1)

Application Number Title Priority Date Filing Date
AUPP3501A Abandoned AUPP350198A0 (en) 1998-05-13 1998-05-13 Method for diagnosing or assessing a predisposition to alzheimer's disease

Country Status (2)

Country Link
AU (1) AUPP350198A0 (en)
WO (1) WO1999058711A1 (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997007213A2 (en) * 1995-08-16 1997-02-27 President And Fellows Of Harvard College Assay for identifying genes causing chromosome non-disjunction
WO1997027296A1 (en) * 1996-01-26 1997-07-31 Hsc Research And Development Limited Partnership Nucleic acids and proteins related to alzheimer's disease, and uses therefor
EP0846764A3 (en) * 1996-11-27 1998-09-30 Smithkline Beecham Plc Glial cell line-derived neurotrophic factor alpha receptor family

Also Published As

Publication number Publication date
WO1999058711A1 (en) 1999-11-18

Similar Documents

Publication Publication Date Title
AU3891499A (en) Diagnostic tests for alzheimer's disease
AU2610901A (en) Predictive diagnostic for alzheimer's disease
AU7606798A (en) Computer system for evaluating a client's condition
AU7708498A (en) Nematode model for alzheimer's disease
AU1837495A (en) Computer assisted methods for diagnosing diseases
HUP0103838A3 (en) Alzheimer's disease secretase
AU7277698A (en) Integrated disease information system
AUPO616697A0 (en) Method for diagnosing psychiatric disorders
GR3033592T3 (en) Method for diagnosing schizophrenia
EP0773797A4 (en) A method of diagnosing alzheimer's disease
AU1403402A (en) Radiopharmaceuticals for diagnosing alzheimer's disease
HUP0003684A3 (en) Diagnostic test for alzheimer's disease
AUPN649395A0 (en) A method for diagnosing alzheimer's disease
IL140222A0 (en) A method and diagnostic kit for detecting alzheimer's disease
AU8346498A (en) Method for diagnosing alzheimer disease
AU8182098A (en) Parkinson's disease tests
AU3068899A (en) Diagnostic assay for late-onset alzheimer's disease
AU9017098A (en) Method for diagnosing alzheimer's disease
AUPP350198A0 (en) Method for diagnosing or assessing a predisposition to alzheimer's disease
AU3803299A (en) Method for diagnosing or assessing a predisposition to alzheimer's disease
GB9706395D0 (en) Methods for clinical diagnosis
EP1031034A4 (en) Method for diagnosing alzheimer's disease
AU1933697A (en) Method for assessing risk to develop psychotic disease
AU2937199A (en) Method for diagnosing epilepsy and related disorders, and kit therefor
AU2001273675A1 (en) Methods and assays for diagnosing alzheimer's disease